Next Capital Management LLC Exelixis, Inc. Transaction History

Next Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $83,325 - $103,895	-5,500 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $4,260 - $5,458	-241 Reduced 4.2%	5,500 $97,000
Q2 2019 Aug 02, 2019	BUY	$18.93 - $24.75 $4,562 - $5,964	241 Added 4.38%	5,741 $123,000
Q4 2018 Feb 12, 2019	BUY	$13.65 - $21.8 $75,075 - $119,900	5,500 New	5,500 $108,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Next Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Next Capital Management LLC with notifications on news.